Yonghua Capital logo

Yonghua Capital

Asia, Shanghai, China, Shanghai

Description

Yonghua Capital (涌铧投资), headquartered in Shanghai, China, stands as one of the country's pioneering private equity and venture capital firms, having been established in 2000. With a long-standing presence in the Chinese investment landscape, the firm has evolved to become a significant player, primarily focusing on growth-stage and pre-IPO investments across a diverse range of high-growth sectors. Its strategic location in Shanghai positions it at the heart of China's economic and technological innovation hubs, allowing it to tap into a wide array of promising opportunities.

The firm manages multiple funds, encompassing both RMB and USD denominated capital, with its assets under management (AUM) reportedly exceeding tens of billions of RMB. Some estimates place their AUM at over 30 billion RMB, which translates to approximately $4.2 billion USD, underscoring their substantial financial capacity. Yonghua Capital's investment philosophy centers on identifying and nurturing companies with strong growth potential, providing not only capital but also strategic guidance to help portfolio companies scale and prepare for public listings or strategic exits.

Yonghua Capital's investment mandate spans several key industries critical to China's economic development, including Technology, Media, and Telecommunications (TMT), healthcare, advanced manufacturing, new energy, and consumer services. The firm boasts a robust track record of successful exits, particularly through initial public offerings (IPOs), having facilitated the listing of numerous companies on various stock exchanges. Typical first check sizes for Yonghua Capital range from approximately $1.4 million USD to $71.4 million USD, reflecting their focus on significant growth rounds and their capacity to lead or co-lead substantial funding rounds for mature startups and pre-IPO companies. This broad investment range allows them to support companies from later-stage venture rounds through to pre-listing stages, making them a versatile partner for ambitious enterprises.

Investor Profile

Yonghua Capital has backed more than 28 startups, with 7 new investments in the last 12 months alone. The firm has led 4 rounds, about 14% of its total and boasts 13 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series Unknown rounds (top funding stages).
  • Majority of deals are located in China, United States, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 1 rounds in the past year.
  • Typical check size: $1.4M – $71.4M.

Stage Focus

  • Series A (36%)
  • Series B (21%)
  • Series Unknown (11%)
  • Series C (11%)
  • Angel (7%)
  • Seed (7%)
  • Series E (4%)
  • Series D (4%)

Country Focus

  • China (57%)
  • United States (36%)
  • United Kingdom (4%)
  • Belgium (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Pharmaceutical
  • Manufacturing
  • Therapeutics
  • Medical Device
  • Health Diagnostics
  • Education
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yonghua Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 3
Applied Ventures
North America, California, United States, Santa Clara
Co-Investments: 2
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Gilead Sciences
North America, California, United States, Foster City
Co-Investments: 2
Mass General Brigham
North America, Massachusetts, United States, Somerville
Co-Investments: 2
GF Securities
Asia, Guangdong, China, Guangzhou
Co-Investments: 2
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 5
6 Dimensions Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 3
HC
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2

Which angels does Yonghua Capital often collaborate with?

RA
Europe, Rostov, Russian Federation, Novaya
Shared Deals: 1

What are some of recent deals done by Yonghua Capital?

MetaLenX

Shenzhen, Guangdong, China

Metalens is a designer and manufacturer of optical devices.

Manufacturing
Series ADec 31, 2024
Amount Raised: $13,702,196
Angitia Biopharmaceuticals

Guangzhou, Guangdong, China

Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.

BiopharmaBiotechnologyHealth CareMedical
Series CDec 11, 2024
Amount Raised: $120,000,000
Xiwi Cloud

Guangzhou, Guangdong, China

Xiwi Cloud is a cloud computing platform that provides complete supply chain quality collaborative management solutions.

Cloud ComputingCloud Data ServicesSupply Chain Management
SeedNov 29, 2024
Matwings Technology

Minhang, Shanghai, China

Matwings is a biotechnology industry that moves evolution methods to design functionally optimized proteins by leveraging a proprietary.

Alternative ProteinBiotechnologyEnergy Efficiency
Series ANov 15, 2024
Amount Raised: $13,826,478
Tianhu Technology

Minhang, Shanghai, China

Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider.

Artificial Intelligence (AI)ConsultingMedical
Series ANov 15, 2024
Amount Raised: $13,826,478
Huaxingyu Electronics

Deyang, Sichuan, China

Huaxingyu Electronics is committed to developing, manufacturing, and marketing printed circuit boards.

Application Specific Integrated Circuit (ASIC)ElectronicsManufacturing
Series UnknownAug 27, 2024
Spear Bio

Weston, Massachusetts, United States

Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.

BiotechnologyHealth CareHealth Diagnostics
Series AJul 29, 2024
Amount Raised: $45,000,000
Spear Bio

Weston, Massachusetts, United States

Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.

BiotechnologyHealth CareHealth Diagnostics
SeedNov 13, 2023
Angitia Biopharmaceuticals

Guangzhou, Guangdong, China

Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.

BiopharmaBiotechnologyHealth CareMedical
Series BOct 19, 2023
Amount Raised: $46,000,000
Haosa

Beijing, Beijing, China

Haosa is a manufacturing company that produces sparkling beverages including fruit juice with lime, peach, and sweet orange flavors.

Food and BeverageFood ProcessingManufacturing
AngelMay 19, 2023